It has also been found that treatment with the mitochondrial Ca2+-buffering protein parvalbumin significantly inhibits the ROS/Nrf2/Notch pathway, MCUR1-induced epithelial− mesenchymal transition and HCC metastasis [159]. This evidence concerns the gene MCUR1 and hepatocellular carcinoma.